Researcher

Ngan Tran Bich Nguyen received her PhD in Molecular and Cell Biology from the National University of Singapore in 2018. Her graduate work focused on understanding the mechanisms of inflammation suppression and resolution to develop therapeutics for inflammatory lung diseases. She then joined the Cell Line Development group at A*STAR’s Bioprocessing Technology Institute (BTI), where she is working on developing targeted integration technologies for CHO cell engineering to produce therapeutic antibodies with improved efficacy.